dc.contributor
[Plans-Rubió P] Agència de Salut Pública de Catalunya, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain
dc.contributor
Departament de Salut
dc.contributor.author
Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration
dc.contributor.author
Plans-Rubió, Pedro
dc.date.accessioned
2025-10-24T10:56:59Z
dc.date.available
2025-10-24T10:56:59Z
dc.date.issued
2024-04-29T11:08:54Z
dc.date.issued
2024-04-29T11:08:54Z
dc.date.issued
2014-05-16
dc.identifier
Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014 May 16;2(8):634-47.
dc.identifier
https://hdl.handle.net/11351/11387
dc.identifier
10.1016/S2213-8587(14)70102-0
dc.identifier.uri
http://hdl.handle.net/11351/11387
dc.description.abstract
Cardiovascular diseases; Chronic kidney diseases; Mortality due to diabetes; Risk factors
dc.description.abstract
Malalties cardiovasculars; Malalties renals cròniques; Mortalitat per diabetis
dc.description.abstract
Enfermedades cardiovasculares; Enfermedades renales crónicas; Mortalidad por diabetes
dc.description.abstract
Background: High blood pressure, blood glucose, serum cholesterol, and BMI are risk factors for cardiovascular diseases and some of these factors also increase the risk of chronic kidney disease and diabetes. We estimated mortality from cardiovascular diseases, chronic kidney disease, and diabetes that was attributable to these four cardiometabolic risk factors for all countries and regions from 1980 to 2010.
Methods: We used data for exposure to risk factors by country, age group, and sex from pooled analyses of population-based health surveys. We obtained relative risks for the effects of risk factors on cause-specific mortality from meta-analyses of large prospective studies. We calculated the population attributable fractions for each risk factor alone, and for the combination of all risk factors, accounting for multicausality and for mediation of the effects of BMI by the other three risks. We calculated attributable deaths by multiplying the cause-specific population attributable fractions by the number of disease-specific deaths. We obtained cause-specific mortality from the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study. We propagated the uncertainties of all the inputs to the final estimates.
Findings: In 2010, high blood pressure was the leading risk factor for deaths due to cardiovascular diseases, chronic kidney disease, and diabetes in every region, causing more than 40% of worldwide deaths from these diseases; high BMI and glucose were each responsible for about 15% of deaths, and high cholesterol for more than 10%. After accounting for multicausality, 63% (10·8 million deaths, 95% CI 10·1-11·5) of deaths from these diseases in 2010 were attributable to the combined effect of these four metabolic risk factors, compared with 67% (7·1 million deaths, 6·6-7·6) in 1980. The mortality burden of high BMI and glucose nearly doubled from 1980 to 2010. At the country level, age-standardised death rates from these diseases attributable to the combined effects of these four risk factors surpassed 925 deaths per 100 000 for men in Belarus, Kazakhstan, and Mongolia, but were less than 130 deaths per 100 000 for women and less than 200 for men in some high-income countries including Australia, Canada, France, Japan, the Netherlands, Singapore, South Korea, and Spain.
Interpretation: The salient features of the cardiometabolic disease and risk factor epidemic at the beginning of the 21st century are high blood pressure and an increasing effect of obesity and diabetes. The mortality burden of cardiometabolic risk factors has shifted from high-income to low-income and middle-income countries. Lowering cardiometabolic risks through dietary, behavioural, and pharmacological interventions should be a part of the global response to non-communicable diseases.
dc.description.abstract
UK Medical Research Council, US National Institutes of Health
dc.format
application/pdf
dc.relation
The Lancet Diabetes & Endocrinology;2(8)
dc.relation
https://doi.org/10.1016/S2213-8587(14)70102-0
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Sistema cardiovascular - Malalties
dc.subject
Ronyons - Malalties
dc.subject
Diabetis - Mortalitat
dc.subject
Cor - Malalties - Factors de risc
dc.subject
DISEASES::Cardiovascular Diseases
dc.subject
DISEASES::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Renal Insufficiency, Chronic::Kidney Failure, Chronic
dc.subject
Other subheadings::Other subheadings::Other subheadings::Other subheadings::/mortality
dc.subject
ENFERMEDADES::enfermedades cardiovasculares
dc.subject
ENFERMEDADES::enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::insuficiencia renal::insuficiencia renal crónica
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::Otros calificadores::/mortalidad
dc.title
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion